Gene id |
629 |
Gene Summary Protein Summary Gene ontology KEGG pathways Diseases PubMed |
Gene Summary
|
Gene Symbol |
CFB Gene UCSC Ensembl |
Aliases |
AHUS4, ARMD14, BF, BFD, CFAB, CFBD, FB, FBI12, GBG, H2-Bf, PBF2 |
Gene name |
complement factor B |
Alternate names |
complement factor B, B-factor, properdin, C3 proaccelerator, C3 proactivator, C3/C5 convertase, glycine-rich beta-glycoprotein, properdin factor B, |
Gene location |
6p21.33 (31946094: 31952083) Exons: 7 NC_000006.12
|
Gene summary(Entrez) |
This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yieldi
|
OMIM |
138470 |
Protein Summary
|
Protein general information
| P00751
Name: Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]
Length: 764 Mass: 85533
|
Sequence |
MGSNLSPQLCLMPFILGLLSGGVTTTPWSLARPQGSCSLEGVEIKGGSFRLLQEGQALEYVCPSGFYPYPVQTRT CRSTGSWSTLKTQDQKTVRKAECRAIHCPRPHDFENGEYWPRSPYYNVSDEISFHCYDGYTLRGSANRTCQVNGR WSGQTAICDNGAGYCSNPGIPIGTRKVGSQYRLEDSVTYHCSRGLTLRGSQRRTCQEGGSWSGTEPSCQDSFMYD TPQEVAEAFLSSLTETIEGVDAEDGHGPGEQQKRKIVLDPSGSMNIYLVLDGSDSIGASNFTGAKKCLVNLIEKV ASYGVKPRYGLVTYATYPKIWVKVSEADSSNADWVTKQLNEINYEDHKLKSGTNTKKALQAVYSMMSWPDDVPPE GWNRTRHVIILMTDGLHNMGGDPITVIDEIRDLLYIGKDRKNPREDYLDVYVFGVGPLVNQVNINALASKKDNEQ HVFKVKDMENLEDVFYQMIDESQSLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAA HCFTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCT EGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEV VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGVVDVCKNQKRQKQVPAHARDFHINLFQVLP WLKEKLQDEDLGFL
|
Structural information |
|
Other Databases |
GeneCards: CFB  Malacards: CFB |
|
GO accession | Term name | Evidence code | Go category |
---|
GO:0004252 |
serine-type endopeptidase activity
|
IEA |
molecular function |
GO:0005576 |
extracellular region
|
IEA |
cellular component |
GO:0006508 |
proteolysis
|
IEA |
biological process |
GO:0006956 |
complement activation
|
IEA |
biological process |
GO:0006508 |
proteolysis
|
IEA |
biological process |
GO:0045087 |
innate immune response
|
IEA |
biological process |
GO:0016787 |
hydrolase activity
|
IEA |
molecular function |
GO:0006957 |
complement activation, al ternative pathway
|
IEA |
biological process |
GO:0002376 |
immune system process
|
IEA |
biological process |
GO:0008233 |
peptidase activity
|
IEA |
molecular function |
GO:0005576 |
extracellular region
|
IEA |
cellular component |
GO:0008236 |
serine-type peptidase act ivity
|
IEA |
molecular function |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0004252 |
serine-type endopeptidase activity
|
TAS |
molecular function |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0005576 |
extracellular region
|
TAS |
cellular component |
GO:0006956 |
complement activation
|
TAS |
biological process |
GO:0006957 |
complement activation, al ternative pathway
|
TAS |
biological process |
GO:0030449 |
regulation of complement activation
|
TAS |
biological process |
GO:0005515 |
protein binding
|
IPI |
molecular function |
GO:0005515 |
protein binding
|
IPI |
molecular function |
GO:0005515 |
protein binding
|
IPI |
molecular function |
GO:0005515 |
protein binding
|
IPI |
molecular function |
GO:0005576 |
extracellular region
|
IEA |
cellular component |
GO:0070062 |
extracellular exosome
|
HDA |
cellular component |
GO:0072562 |
blood microparticle
|
HDA |
cellular component |
GO:0005615 |
extracellular space
|
HDA |
cellular component |
GO:0006957 |
complement activation, al ternative pathway
|
NAS |
biological process |
GO:0001848 |
complement binding
|
TAS |
molecular function |
|
|
Pathway id | Pathway name |
hsa05150 | Staphylococcus aureus infection | hsa04610 | Complement and coagulation cascades | |
|
Associated diseases |
References |
Age-related macular degeneration | KEGG:H00821 |
Atypical hemolytic uremic syndrome | KEGG:H01434 |
Age-related macular degeneration | KEGG:H00821 |
Atypical hemolytic uremic syndrome | KEGG:H01434 |
Lupus nephritis | PMID:21893562 |
Atypical hemolytic-uremic syndrome | PMID:17182750 |
Atypical hemolytic-uremic syndrome | PMID:20513133 |
Sickle cell anemia | PMID:10440069 |
Sickle cell anemia | PMID:12793071 |
factor VIII deficiency | PMID:6912882 |
Beta thalassemia | PMID:6914868 |
Behcet's disease | PMID:6900632 |
Breast cancer | PMID:15274022 |
systemic scleroderma | PMID:2803327 |
macular degeneration | PMID:23112567 |
Psoriasis | PMID:6559061 |
Diabetic retinopathy | PMID:23864767 |
autosomal dominant polycystic kidney disease | PMID:24494798 |
type 1 diabetes mellitus | PMID:3907907 |
type 1 diabetes mellitus | PMID:19000152 |
acute lymphocytic leukemia | PMID:6958349 |
Hypospermatogenesis | MIK: 28361989 |
Male factor infertility | MIK: 29961538 |
Spermatogenic defects | MIK: 31037746 |
Teratozoospermia | MIK: 17327269 |
|
|
PMID |
Condition |
Mutation |
Ethnicity |
Population details |
Infertility_type |
Associated_genes |
Abstract |
17327269 |
Teratozoos permia
|
|
|
13 (5 controls, 8 cases)
|
Male infertility |
GSE6967 analyzed by GEO2R (cutoff 1.5 fold)
|
Show abstract |
29961538 |
Male facto r infertil ity
|
|
|
318 (128 couple s presenting wi th OAT (MF) and 118 maternal a ge-matched cont rol (no MF) sub jects undergoin g infertility t reatment, 72 su rplus cryoprese rved blastocyst s)
|
Male infertility |
RNA-seq
|
Show abstract |
28361989 |
Hyposperma togenesis
|
|
|
6 (3 controls, 3 Klienfelter s yndrome
|
Male infertility |
Microarray
|
Show abstract |
31037746 |
Spermatoge nic defect s
|
|
|
16 (1 control, 15 cases)
|
Male infertility |
GSE6023 analyzed using GEO2R
|
Show abstract |
|